Skip to content

Maze Therapeutics, Inc. (MAZE) Insider Trading -- Recent Executive & Director Transactions

14 insiders reported 152 Form 4 transactions for Maze Therapeutics, Inc. (MAZE) over the past 18 months (most recent 2026-10-02). Recent activity: Coloma Jason V (Chief Executive Officer) Sell 2,593 shares, Bernstein Harold (President, R&D & CMO) Buy 16,141 shares, Coloma Jason V (Chief Executive Officer) Sell 31,908 shares, Bernstein Harold (President, R&D & CMO) Sell 16,141 shares, Dandekar Atul (CSBO) Buy 7,500 shares. Source: SEC Form 4.

DateInsiderTitleTypeSharesValue
2026-10-02Coloma Jason VChief Executive OfficerSell2,593$70,073
2026-10-02Bernstein HaroldPresident, R&D & CMOBuy16,141$168,189
2026-10-02Coloma Jason VChief Executive OfficerSell31,908$862,186
2026-10-02Bernstein HaroldPresident, R&D & CMOSell16,141$434,743
2026-10-01Dandekar AtulCSBOBuy7,500$78,150
2026-10-01Dandekar AtulCSBOSell7,500$202,921
2026-09-08Bernstein HaroldPresident, R&D & CMOSell9,705$254,502
2026-09-04Courtney PhillipsGC and Corp. SecretarySell243$6,590
2026-09-04Courtney PhillipsGC and Corp. SecretarySell1,738$45,841
2026-09-04Dandekar AtulCSBOSell2,800$73,853
2026-09-04Bernstein HaroldPresident, R&D & CMOSell4,481$118,191
2026-09-04Coloma Jason VChief Executive OfficerSell1,375$37,292
2026-09-04Coloma Jason VChief Executive OfficerSell9,852$259,856
2026-09-04Dandekar AtulCSBOSell391$10,604
2026-09-04Bernstein HaroldPresident, R&D & CMOSell625$16,951
2026-09-04Coloma Jason VChief Executive OfficerSell11,282$293,482
2026-09-04Courtney PhillipsGC and Corp. SecretarySell1,990$51,766
2026-09-04Dandekar AtulCSBOSell3,207$83,425
2026-09-04Bernstein HaroldPresident, R&D & CMOSell5,130$133,448
2026-09-04Coloma Jason VChief Executive OfficerSell129$3,325
2026-09-04Courtney PhillipsGC and Corp. SecretarySell22$567
2026-09-04Dandekar AtulCSBOSell36$929
2026-09-04Bernstein HaroldPresident, R&D & CMOSell59$1,521
2026-09-03Coloma Jason VChief Executive OfficerSell2,593$68,214
2026-09-03Courtney PhillipsGC and Corp. SecretaryBuy11,000$0

Source: SEC Form 4 filings · as of 2026-10-02